E-LIB Suche - Ergebnisse für: Lenain, Marie-Anne - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Bortezomib, thalidomide, and dexamethasone with or without ..:

Moreau, Philippe ; Attal, Michel ; Hulin, Cyrille...
The Lancet. 394 (2019) 10192 - p. 29-38 , 2019

Link: https://doi.org/10.1016/..

2

On the elasto-viscoplastic behavior of the Ti5553 alloy:

Bettaieb, Mohamed Ben ; Hoof, Thibaut Van ; Pardoen, Thomas...
Materials Science and Engineering: A. 617 (2014) - p. 97-109 , 2014

Link: https://doi.org/10.1016/..

3

Planktonic microbial community responses to added copper:

Le Jeune, Anne-Hélène ; Charpin, Marie ; Sargos, Denis...
Aquatic Toxicology. 83 (2007) 3 - p. 223-237 , 2007

Link: https://doi.org/10.1016/..

4

Effect of copper sulphate treatment on natural phytoplankto..:

Le Jeune, Anne-Hélène ; Charpin, Marie ; Deluchat, Véronique...
Aquatic Toxicology. 80 (2006) 3 - p. 267-280 , 2006

Link: https://doi.org/10.1016/..

5

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

6

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

7

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

8

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

9

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

10

Real-world study of the efficacy and safety of belantamab m..:

Talbot, Alexis ; Bobin, Arthur ; Tabone, Léa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543185/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

12

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

13

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

14

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anaïs ; Lauwers-Cances, Valérie ; Perrot, Aurore...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153521/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Bortezomib and high-dose melphalan conditioning regimen in ..:

Roussel, Murielle ; Lauwers-Cances, Valérie ; Macro, Margaret...
boreal:260662. , 2022

Link: http://hdl.handle.net/20..

1-15